Ignite Creation Date:
2024-05-06 @ 6:43 PM
Last Modification Date:
2024-10-26 @ 2:53 PM
Study NCT ID:
NCT05768178
Status:
RECRUITING
Last Update Posted:
2023-10-25
First Post:
2023-02-22
Brief Title:
DETERMINE Trial Treatment Arm 05 Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers
Sponsor:
Cancer Research UK
Organization:
Cancer Research UK
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Thyroid Carcinoma Anaplastic |
| Solid Tumor |
| Haematological Malignancy |
| Melanoma |
| Thyroid Cancer Papillary |
| Ovarian Neoplasms |
| Colorectal Neoplasms |
| Laryngeal Neoplasms |
| Carcinoma Non-Small-Cell Lung |
| Glioma |
| Multiple Myeloma |
| Erdheim-Chester Disease |
Keywords:
| Name | View |
|---|---|
| Vemurafenib | View |
| Adult | View |
| Antineoplastic Agents | View |
| Cancer | View |
| Malignancy | View |
| Malignant Neoplasms | View |
| Molecular Targeted Therapy | View |
| Mutation | View |
| Neoplasms by Histologic Type | View |
| Neoplasms by Site | View |
| Precision Medicine | View |
| Cobimetinib | View |
| Proto-Oncogene Proteins B-raf | View |
| Rare | View |
| Tumour-agnostic | View |